BIA 6-512 (trans-resveratrol)

trans-resveratrol · Bial - Portela C S.A.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BIA 6-512 (trans-resveratrol), covering 2017-03-27 to 2017-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics [Phase 1]

See pricing